In January, while most of the world was just keeping a watching eye on the Covid situation in Wuhan, a Kiwi company was kicking into action.
Fisher & Paykel Healthcare boss Lewis Gradon could see what was coming. He says because of the nature of his business, it is "semi-prepared" for a pandemic at all times. He knew Fisher & Paykel Healthcare would play a huge role looking after the world's Covid patients.
"If you can cast your mind back to then, it was a very scary thought. Even scarier for us, in that two of the primary respiratory therapies used to treat these Covid patients; ventilators and nasal high-flow therapy; we're 70-80 per cent of the world's supply. We were thinking 'boy, a lot of treating these patients is going to fall on us providing the equipment'."
The first thing the company did was start selling the 12-14 weeks of stock it was holding, while bringing in more people and more shifts to keep making the equipment required. But that wasn't as simple as it sounds.
"As a growth business, we're almost always sitting in a half-empty building or we've got a building almost completed. In January we had just completed our second manufacturing building in Mexico.